221 related articles for article (PubMed ID: 27503444)
21. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution.
Muratori F; Frenos F; Bettini L; Matera D; Mondanelli N; Scorianz M; Cuomo P; Scoccianti G; Beltrami G; Greto D; Livi L; Baldi G; Roselli G; Capanna R; Campanacci DA
J Orthop Sci; 2018 Nov; 23(6):1038-1044. PubMed ID: 30007495
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults.
Tran PT; Hara W; Su Z; Lin HJ; Bendapudi PK; Norton J; Teng N; King CR; Kapp DS
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1146-53. PubMed ID: 18394818
[TBL] [Abstract][Full Text] [Related]
23. The modified Glasgow prognostic score in patients undergoing surgery for bone and soft tissue sarcoma.
Morhij R; Mahendra A; Jane M; McMillan DC
J Plast Reconstr Aesthet Surg; 2017 May; 70(5):618-624. PubMed ID: 28342782
[TBL] [Abstract][Full Text] [Related]
24. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Dalal KM; Kattan MW; Antonescu CR; Brennan MF; Singer S
Ann Surg; 2006 Sep; 244(3):381-91. PubMed ID: 16926564
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.
Chung PW; Deheshi BM; Ferguson PC; Wunder JS; Griffin AM; Catton CN; Bell RS; White LM; Kandel RA; O'Sullivan B
Cancer; 2009 Jul; 115(14):3254-61. PubMed ID: 19472403
[TBL] [Abstract][Full Text] [Related]
26. The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
Goy BW; Syed S; Padmanabhan A; Burchette RJ; Helmstedter CS
Radiother Oncol; 2021 Dec; 165():174-178. PubMed ID: 34758339
[TBL] [Abstract][Full Text] [Related]
27. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.
Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Le Pèchoux C; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Catton C; Casali PG; Wunder JS; Gronchi A
Eur J Cancer; 2018 Dec; 105():19-27. PubMed ID: 30384013
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
Kang S; Han I; Lee S; Kim W; Kim H
Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
[TBL] [Abstract][Full Text] [Related]
29. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
30. Differences in recurrence and survival of extremity liposarcoma subtypes.
Vos M; Koseła-Paterczyk H; Rutkowski P; van Leenders GJLH; Normantowicz M; Lecyk A; Sleijfer S; Verhoef C; Grünhagen DJ
Eur J Surg Oncol; 2018 Sep; 44(9):1391-1397. PubMed ID: 29673808
[TBL] [Abstract][Full Text] [Related]
31. Primary high-grade soft-tissue sarcoma of the buttock: a rare but distinct clinical entity.
Soyfer V; Corn BW; Bickels J; Merimsky O
Br J Radiol; 2016 Jun; 89(1062):20151017. PubMed ID: 27043867
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and oncological outcomes of 122 head and neck soft tissue sarcoma patients treated at a single institution.
Park JT; Roh JL; Kim SO; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):248-55. PubMed ID: 25001093
[TBL] [Abstract][Full Text] [Related]
33. [Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity].
Li Y; Niu XH; Xu HR
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):964-9. PubMed ID: 22333413
[TBL] [Abstract][Full Text] [Related]
34. Somatic Leiomyosarcoma of the Soft Tissues: A Single-Institutional Analysis of Factors Predictive of Survival in 164 Patients.
Harati K; Daigeler A; Lange K; Niggemann H; Stricker I; Steinau HU; Lehnhardt M; Goertz O
World J Surg; 2017 Jun; 41(6):1534-1541. PubMed ID: 28116485
[TBL] [Abstract][Full Text] [Related]
35. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
[TBL] [Abstract][Full Text] [Related]
36. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.
Potter BK; Hwang PF; Forsberg JA; Hampton CB; Graybill JC; Peoples GE; Stojadinovic A
J Bone Joint Surg Am; 2013 Oct; 95(20):e151. PubMed ID: 24132366
[TBL] [Abstract][Full Text] [Related]
37. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.
Schaefer IM; Hornick JL; Barysauskas CM; Raut CP; Patel SA; Royce TJ; Fletcher CDM; Baldini EH
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):375-383. PubMed ID: 28463157
[TBL] [Abstract][Full Text] [Related]
38. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.
Bautista N; Su W; O'Connell TX
Am Surg; 2000 Sep; 66(9):832-6. PubMed ID: 10993610
[TBL] [Abstract][Full Text] [Related]
39. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.
Tan MC; Brennan MF; Kuk D; Agaram NP; Antonescu CR; Qin LX; Moraco N; Crago AM; Singer S
Ann Surg; 2016 Mar; 263(3):593-600. PubMed ID: 25915910
[TBL] [Abstract][Full Text] [Related]
40. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution.
Gronchi A; Casali PG; Fiore M; Mariani L; Lo Vullo S; Bertulli R; Colecchia M; Lozza L; Olmi P; Santinami M; Rosai J
Cancer; 2004 Jun; 100(11):2448-55. PubMed ID: 15160351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
